Having identified HOXD9 as potential Wnt pathway candidate genes regulated by ITF2, we studied its clinical translational application in the cohort of NSCLC patients used for the RNA-seq analysis and in the public databases TCGA and KMplotter. The gene discussed is HOXD9; the disease is non-small cell lung carcinoma.